Novel Ahp-cyclodepsipeptide-based HTRA inhibitors for the treatment of macular degeneration (HTRA1) or cell death in reperfusion-ischemia (HTRA2).
[更多]
The invention describes a preparation as electrolyte for LiTFSi-containing lithium batteries. It contains cyclopentane carbonitrile and methoxyprionitrile as its main constituent and prevents corrosion on aluminum current conductors.
[更多]
The invention concerns a device and process for minimizing the polarization deviation of light at the output of a polarization (PM) optical fiber under disruptive influences of temperature, pressure and location changes in the environment.
[更多]
| |<首頁 <-上一頁 下一頁-> 末頁>| |
